{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T21:35:01Z","timestamp":1775338501988,"version":"3.50.1"},"reference-count":73,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Continuum"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1212\/con.0000000000000562","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T13:59:10Z","timestamp":1518530350000},"page":"96-129","source":"Crossref","is-referenced-by-count":31,"title":["Neurocutaneous Disorders"],"prefix":"10.1212","volume":"24","author":[{"given":"Tena","family":"Rosser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"1","key":"e_1_3_1_2_2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/jhg.2015.114","article-title":"Recent advances in RASopathies","volume":"61","author":"Aoki Y","year":"2016","unstructured":"Aoki Y Niihori T Inoue S Matsubara Y. Recent advances in RASopathies. J Hum Genet 2016;61(1):33\u201339. doi:10.1038\/jhg.2015.114.","journal-title":"J Hum Genet"},{"key":"e_1_3_1_3_2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev-genom-091212-153523","article-title":"The RASopathies","volume":"14","author":"Rauen K","year":"2013","unstructured":"Rauen K. The RASopathies. Annu Rev Genomics Hum Genet 2013;14:355\u2013369. doi:10.1146\/annurev-genom-091212-153523.","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"2","key":"e_1_3_1_4_2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jdermsci.2015.04.005","article-title":"Mammalian target of apamycin and tuberous sclerosis complex","volume":"79","author":"Wataya-Kaneda M","year":"2015","unstructured":"Wataya-Kaneda M. Mammalian target of apamycin and tuberous sclerosis complex. J Dermatol Sci 2015;79(2):93\u2013100. doi:10.1016\/j.jdermsci.2015.04.005.","journal-title":"J Dermatol Sci"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2012.12.002"},{"issue":"6","key":"e_1_3_1_6_2","first-page":"1355","article-title":"Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales","volume":"111","author":"Huson SM","year":"1988","unstructured":"Huson SM Harper PS Compston DA. Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain 1988;111(pt 6):1355\u20131381. doi:10.1093\/brain\/111.6.1355.","journal-title":"Brain"},{"issue":"1","key":"e_1_3_1_7_2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0092-8674(90)90252-A","article-title":"Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus","volume":"62","author":"Viskochil D","year":"1990","unstructured":"Viskochil D Buchberg AM Xu G. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 1990;62(1):187\u2013192. doi:10.1016\/0092-8674(90)90252-A.","journal-title":"Cell"},{"key":"e_1_3_1_8_2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.semcdb.2016.02.007","article-title":"Neurofibromatosis type 1: Fundamental insights into cell signaling and cancer","volume":"52","author":"Rad E","year":"2016","unstructured":"Rad E Tee AR. Neurofibromatosis type 1: Fundamental insights into cell signaling and cancer. Semin Cell Dev Biol 2016;52:39\u201346. doi:10.1016\/j.semcdb.2016.02.007.","journal-title":"Semin Cell Dev Biol"},{"issue":"5","key":"e_1_3_1_9_2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/archneur.1988.00520290115023","article-title":"Neurofibromatosis Conference Statement","volume":"45","author":"National Institutes of Health Consensus Development Conference","year":"1988","unstructured":"National Institutes of Health Consensus Development Conference. Neurofibromatosis Conference Statement. Arch Neurol 1988;45(5):575\u2013578. doi:10.1001\/archneur.1988.00520290115023.","journal-title":"Arch Neurol"},{"issue":"7","key":"e_1_3_1_10_2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/jmg.2008.065243","article-title":"SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype","volume":"46","author":"Pasmant E","year":"2009","unstructured":"Pasmant E Sabbagh A Hanna N. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype. J Med Genet 2009;46(7):425\u2013430. doi:10.1136\/jmg.2008.065243.","journal-title":"J Med Genet"},{"issue":"6","key":"e_1_3_1_11_2","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1542\/peds.90.6.924","article-title":"Diagnostic outcome in children with multiple caf\u00e9 au lait spots","volume":"90","author":"Korf BR","year":"1992","unstructured":"Korf BR. Diagnostic outcome in children with multiple caf\u00e9 au lait spots. Pediatrics 1992;90(6):924\u2013927.","journal-title":"Pediatrics"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2010.10.041"},{"issue":"10","key":"e_1_3_1_13_2","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1212\/WNL.58.10.1461","article-title":"Plexiform neurofibromas in NF1: toward biologic-based therapy","volume":"58","author":"Packer RJ","year":"2002","unstructured":"Packer RJ Gutmann DH Rubenstein A. Plexiform neurofibromas in NF1: toward biologic-based therapy. Neurology 2002;58(10):1461\u20131470. doi:10.1212\/WNL.58.10.1461.","journal-title":"Neurology"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nos287"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21107"},{"issue":"4","key":"e_1_3_1_16_2","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jpeds.2015.07.001","article-title":"The use of magnetic resonance imaging screening for optic pathway gliomas in children with neurofibromatosis type 1","volume":"167","author":"Prada CE","year":"2015","unstructured":"Prada CE Hufnagel RB Hummel TR. The use of magnetic resonance imaging screening for optic pathway gliomas in children with neurofibromatosis type 1. J Pediatr 2015;167(4):851\u2013856. doi:10.1016\/j.jpeds.2015.07.001.","journal-title":"J Pediatr"},{"issue":"3","key":"e_1_3_1_17_2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/ajmg.a.36338","article-title":"Longitudinal assessment of cognition and T2-hyperintensities in NF1: an 18-year study","volume":"164","author":"Payne JM","year":"2013","unstructured":"Payne JM Pickering T Porter M. Longitudinal assessment of cognition and T2-hyperintensities in NF1: an 18-year study. Am J Med Genet A 2013;164A(3):661\u2013665. doi:10.1002\/ajmg.a.36338.","journal-title":"Am J Med Genet A"},{"issue":"3","key":"e_1_3_1_18_2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/jnnp.2009.179630","article-title":"Brain structure and function in neurofibromatosis type 1: current concepts and future directions","volume":"81","author":"Payne JM","year":"2010","unstructured":"Payne JM Moharis MD Webster R North KN. Brain structure and function in neurofibromatosis type 1: current concepts and future directions. J Neurol Neurosurg Psychiatry 2010;81(3):304\u2013309. doi:10.1136\/jnnp.2009.179630.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/87565641.2012.695831"},{"issue":"6","key":"e_1_3_1_20_2","doi-asserted-by":"crossref","first-page":"e1642","DOI":"10.1542\/peds.2013-1868","article-title":"Neurofibromatosis typ1 and autism spectrum disorder","volume":"132","author":"Garg S","year":"2013","unstructured":"Garg S Green J Leadbitter K. Neurofibromatosis typ1 and autism spectrum disorder. Pediatrics 2013;132(6):e1642\u2013e1648. doi:10.1542\/peds.2013-1868.","journal-title":"Pediatrics"},{"issue":"2","key":"e_1_3_1_21_2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ajmg.c.30296","article-title":"The musculoskeletal phenotype of the RASopathies","volume":"157","author":"Stevenson DA","year":"2011","unstructured":"Stevenson DA Yang FC. The musculoskeletal phenotype of the RASopathies. Am J Med Genet C Semin Med Genet 2011;157C(2):90\u2013103. doi:10.1002\/ajmg.c.30296.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"4","key":"e_1_3_1_22_2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/jmg.2008.061895","article-title":"Bone health and fracture rate in individuals with neurofibromatosis 1 (NF1)","volume":"46","author":"Tucker T","year":"2009","unstructured":"Tucker T Schnabel C Hartmann M. Bone health and fracture rate in individuals with neurofibromatosis 1 (NF1). J Med Genet 2009;46(4):259\u2013265. doi:10.1136\/jmg.2008.061895.","journal-title":"J Med Genet"},{"issue":"11","key":"e_1_3_1_23_2","doi-asserted-by":"crossref","first-page":"e49222","DOI":"10.1371\/journal.pone.0049222","article-title":"Loss of NF1 expression in human endothelial cells promotes autonomous proliferation and altered vascular morphogenesis","volume":"7","author":"Bajaj A","year":"2012","unstructured":"Bajaj A Li QF Zheng Q Pumiglia K. Loss of NF1 expression in human endothelial cells promotes autonomous proliferation and altered vascular morphogenesis. PLoS One 2012;7(11):e49222. doi:10.1371\/journal.pone.0049222.","journal-title":"PLoS One"},{"issue":"1","key":"e_1_3_1_24_2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1161\/STROKEAHA.115.011406","article-title":"Increased risk of cerebrovascular disease among patients with neurofibromatosis type 1: population-based approach","volume":"47","author":"Terry AR","year":"2016","unstructured":"Terry AR Jordan JT Schwamm L Plotkin SR. Increased risk of cerebrovascular disease among patients with neurofibromatosis type 1: population-based approach. Stroke 2016;47(1):60\u201365. doi:10.1161\/STROKEAHA.115.011406.","journal-title":"Stroke"},{"issue":"3","key":"e_1_3_1_25_2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1542\/peds.2007-3364","article-title":"Committee on Genetics. Health supervision for children with neurofibromatosis","volume":"121","author":"Hersh JH","year":"2008","unstructured":"Hersh JH. Committee on Genetics. Health supervision for children with neurofibromatosis. Pediatrics 2008;121(3):633\u2013642. doi:10.1542\/peds.2007-3364.","journal-title":"Pediatrics"},{"issue":"5","key":"e_1_3_1_26_2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/neuonc\/nov200","article-title":"Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2 and schwannomatosis","volume":"18","author":"Blakely JO","year":"2016","unstructured":"Blakely JO Plotkin SR. Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2 and schwannomatosis. Neuro Oncol 2016;18(5):624\u2013638. doi:10.1093\/neuonc\/nov200.","journal-title":"Neuro Oncol"},{"issue":"3","key":"e_1_3_1_27_2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jama.300.3.287","article-title":"Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial","volume":"300","author":"Krab LC","year":"2008","unstructured":"Krab LC de Goede-Bolder A Aarsen FK. Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial. JAMA 2008;300(3):287\u2013294. doi:10.1001\/jama.300.3.287.","journal-title":"JAMA"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng2113"},{"issue":"7","key":"e_1_3_1_29_2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/jmg.2008.065243","article-title":"SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype","volume":"46","author":"Pasmant E","year":"2009","unstructured":"Pasmant E Sabbagh A Hanna N. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype. J Med Genet 2009;46(7):425\u2013430. doi:10.1136\/jmg.2008.065243.","journal-title":"J Med Genet"},{"issue":"1","key":"e_1_3_1_30_2","doi-asserted-by":"crossref","first-page":"E1985","DOI":"10.1002\/humu.21404","article-title":"Legius syndrome in fourteen families","volume":"32","author":"Denayer E","year":"2011","unstructured":"Denayer E Chmara M Brems H. Legius syndrome in fourteen families. Hum Mutat 2011;32(1):E1985\u2013E1998. doi:10.1002\/humu.21404.","journal-title":"Hum Mutat"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.otc.2015.02.005"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.12.042"},{"issue":"16","key":"e_1_3_1_33_2","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.febslet.2014.04.001","article-title":"Molecular insights into NF2\/Merlin tumor suppressor function","volume":"588","author":"Giancotti FG","year":"2014","unstructured":"Giancotti FG Cooper J. Molecular insights into NF2\/Merlin tumor suppressor function. FEBS Lett 2014;588(16):2743\u20132752. doi:10.1016\/j.febslet.2014.04.001.","journal-title":"FEBS Lett"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000035638.74084.F4"},{"issue":"304","key":"e_1_3_1_35_2","first-page":"603","article-title":"A clinical study of type 2 neurofibromatosis","volume":"84","author":"Evans DG","year":"1992","unstructured":"Evans DG Huson SM Donnai D. A clinical study of type 2 neurofibromatosis. Q J Med 1992;84(304):603\u2013618.","journal-title":"Q J Med"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.spen.2015.10.008"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.29.12.847"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.3171\/spi.2005.2.5.0574"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.3171\/2010.11.SPINE10350"},{"issue":"5","key":"e_1_3_1_40_2","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/brain\/awf115","article-title":"Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2","volume":"125","author":"Sperfeld AD","year":"2002","unstructured":"Sperfeld AD Hein C Schr\u00f6der JM. Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2. Brain 2002;125(pt 5):996\u20131004. doi:10.1093\/brain\/awf115.","journal-title":"Brain"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2011.01816.x"},{"issue":"4","key":"e_1_3_1_42_2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000342251","article-title":"LEOPARD syndrome: clinical features and gene mutations","volume":"3","author":"Mart\u00ednez-Quintana E","year":"2012","unstructured":"Mart\u00ednez-Quintana E Rodr\u00edguez-Gonz\u00e1lez F. LEOPARD syndrome: clinical features and gene mutations. Mol Syndromol 2012;3(4):145\u2013157. doi:10.1159\/000342251.","journal-title":"Mol Syndromol"},{"issue":"5","key":"e_1_3_1_43_2","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1136\/jmg.2003.013466","article-title":"Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD syndrome","volume":"41","author":"Sarkozy A","year":"2004","unstructured":"Sarkozy A Conti E Digilio MC. Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD syndrome. J Med Genet 2004;41(5):e68. doi:10.1136\/jmg.2003.013466.","journal-title":"J Med Genet"},{"issue":"2","key":"e_1_3_1_44_2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/341528","article-title":"Grouping of multiple-lentigines\/LEOPARD and Noonan syndromes on the PTPN11 gene","volume":"71","author":"Digilio MC","year":"2002","unstructured":"Digilio MC Conti E Sarkozy A. Grouping of multiple-lentigines\/LEOPARD and Noonan syndromes on the PTPN11 gene. Am J Hum Genet 2002;71(2):389\u2013394. doi:10.1086\/341528.","journal-title":"Am J Hum Genet"},{"key":"e_1_3_1_45_2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1172-3-13","article-title":"Leopard syndrome","volume":"3","author":"Sarkozy A","year":"2008","unstructured":"Sarkozy A Digilio MC Dallapiccola B. Leopard syndrome. Orphanet J Rare Dis 2008;3:13. doi:10.1186\/1750-1172-3-13.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"e_1_3_1_46_2","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.amjcard.2007.03.093","article-title":"Prevalence and clinical significance of cardiovascular abnormalities in patients with the LEOPARD syndrome","volume":"100","author":"Limongelli G","year":"2007","unstructured":"Limongelli G Pacileo G Marino B. Prevalence and clinical significance of cardiovascular abnormalities in patients with the LEOPARD syndrome. Am J Cardiol 2007;100(4):736\u2013741. doi:10.1016\/j.amjcard.2007.03.093.","journal-title":"Am J Cardiol"},{"issue":"4","key":"e_1_3_1_47_2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Northrup H","year":"2013","unstructured":"Northrup H Krueger DA. International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatric Neurol 2013;49(4):243\u2013254. doi:10.1016\/j.pediatrneurol.2013.08.001.","journal-title":"Pediatric Neurol"},{"issue":"5","key":"e_1_3_1_48_2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/(SICI)1098-1004(199911)14:5<412::AID-HUMU7>3.0.CO;2-K","article-title":"Analysis of both TSC1 and TSC2 for germline mutations in 126 unrelated patients with tuberous sclerosis","volume":"14","author":"Niida Y","year":"1999","unstructured":"Niida Y Lawrence-Smith N Banwell A. Analysis of both TSC1 and TSC2 for germline mutations in 126 unrelated patients with tuberous sclerosis. Hum Mutat 1999;14(5):412\u2013422. doi:10.1002\/(SICI)1098-1004(199911)14:5<412::AID-HUMU7>3.0.CO;2-K.","journal-title":"Hum Mutat"},{"issue":"5","key":"e_1_3_1_49_2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/pde.12567","article-title":"Tuberous sclerosis complex: an update for dermatologists","volume":"32","author":"Jacks SK","year":"2015","unstructured":"Jacks SK Witman PM. Tuberous sclerosis complex: an update for dermatologists. Pediatr Dermatol 2015;32(5):563\u2013570. doi:10.1111\/pde.12567.","journal-title":"Pediatr Dermatol"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2013.08.017"},{"issue":"4","key":"e_1_3_1_51_2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00381-014-2383-x","article-title":"Subependymal giant cell astrocytoma: current concepts, management, and future directions","volume":"30","author":"Ouyang T","year":"2014","unstructured":"Ouyang T Zhang N Benjamin T. Subependymal giant cell astrocytoma: current concepts, management, and future directions. Childs Nerv Syst 2014;30(4):561\u2013570. doi:10.1007\/s00381-014-2383-x.","journal-title":"Childs Nerv Syst"},{"issue":"4","key":"e_1_3_1_52_2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","article-title":"Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Krueger DA","year":"2013","unstructured":"Krueger DA Northrup H. International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 2013;49(4):255\u2013265. doi:10.1016\/j.pediatrneurol.2013.08.002.","journal-title":"Pediatr Neurol"},{"key":"e_1_3_1_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2009.02474.x"},{"issue":"24","key":"e_1_3_1_54_2","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1212\/WNL.0b013e318259e2cf","article-title":"Evidence-based guideline update: medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society","volume":"78","author":"Go CY","year":"2012","unstructured":"Go CY Mackay MT Weiss SK. Evidence-based guideline update: medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2012;78(24):1974\u20131980. doi:10.1212\/WNL.0b013e318259e2cf.","journal-title":"Neurology"},{"key":"e_1_3_1_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00069-1"},{"issue":"6","key":"e_1_3_1_56_2","doi-asserted-by":"crossref","first-page":"e001493","DOI":"10.1161\/JAHA.114.001493","article-title":"Cardiovascular manifestations of tuberous sclerosis complex and summary of the revised diagnostic criteria and surveillance and management recommendations from the International Tuberous Sclerosis Consensus Group","volume":"3","author":"Hinton RB","year":"2014","unstructured":"Hinton RB Prakash A Romp RL. Cardiovascular manifestations of tuberous sclerosis complex and summary of the revised diagnostic criteria and surveillance and management recommendations from the International Tuberous Sclerosis Consensus Group. J Am Heart Assoc 2014;3(6):e001493. doi:10.1161\/JAHA.114.001493.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"e_1_3_1_57_2","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.juro.2015.07.126","article-title":"Update on the diagnosis and management of renal angiomyolipoma","volume":"195","author":"Flum AS","year":"2016","unstructured":"Flum AS Hamoui N Said MA. Update on the diagnosis and management of renal angiomyolipoma. J Urol 2016;195(4 pt 1):834\u2013846. doi:10.1016\/j.juro.2015.07.126.","journal-title":"J Urol"},{"key":"e_1_3_1_58_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-015-9750-6"},{"issue":"21","key":"e_1_3_1_59_2","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1056\/NEJMoa1213507","article-title":"Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ","volume":"368","author":"Shirley MD","year":"2013","unstructured":"Shirley MD Tang H Gallione CJ. Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med 2013;368(21):1971\u20131979. doi:10.1056\/NEJMoa1213507.","journal-title":"N Engl J Med"},{"key":"e_1_3_1_60_2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/CLEP.S50780","article-title":"Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis","volume":"7","author":"Taveira-DaSilva AM","year":"2015","unstructured":"Taveira-DaSilva AM Moss J. Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis. Clin Epidemiol 2015;7:249\u2013257. doi:10.2147\/CLEP.S50780.","journal-title":"Clin Epidemiol"},{"key":"e_1_3_1_61_2","volume-title":"Handbook of clinical neurology. Neurocutaneous syndromes","author":"Comi AM","year":"2015","unstructured":"Comi AM. Sturge-Weber syndrome. In: Islam MP Roach ES, editors. Handbook of clinical neurology. Neurocutaneous syndromes Vol 132, 3rd series. Philadelphia, PA: Elsevier, 2015."},{"key":"e_1_3_1_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.spen.2015.10.005"},{"issue":"1","key":"e_1_3_1_63_2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/088307389501000113","article-title":"Sturge-Weber syndrome: age of onset of seizures and glaucoma and the prognosis for affected children","volume":"10","author":"Sujansky E","year":"1995","unstructured":"Sujansky E Conradi S. Sturge-Weber syndrome: age of onset of seizures and glaucoma and the prognosis for affected children. J Child Neurol 1995;10(1):49\u201358. doi:10.1177\/088307389501000113.","journal-title":"J Child Neurol"},{"key":"e_1_3_1_64_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2009.02072.x"},{"issue":"5","key":"e_1_3_1_65_2","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1080\/13854046.2010.485133","article-title":"Neuropsychological features and risk factors in children with Sturge-Weber syndrome: four case reports","volume":"24","author":"Zabel TA","year":"2010","unstructured":"Zabel TA Reesman J Wodka EL. Neuropsychological features and risk factors in children with Sturge-Weber syndrome: four case reports. Clin Neuropsychol 2010;24(5):841\u2013859. doi:10.1080\/13854046.2010.485133.","journal-title":"Clin Neuropsychol"},{"key":"e_1_3_1_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2013.10.003"},{"issue":"2","key":"e_1_3_1_67_2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/0883073812463607","article-title":"Aspirin use in Sturge-Weber syndrome: side effects and clinical outcomes","volume":"28","author":"Lance EI","year":"2013","unstructured":"Lance EI Sreenivasan AK Zabel TA. Aspirin use in Sturge-Weber syndrome: side effects and clinical outcomes. J Child Neurol 2013;28(2):213\u2013218. doi:10.1177\/0883073812463607.","journal-title":"J Child Neurol"},{"issue":"3","key":"e_1_3_1_68_2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/seiz.2001.0629","article-title":"Prophylactic anti-epileptic treatment in Sturge-Weber disease","volume":"11","author":"Vill D","year":"2002","unstructured":"Vill D Enjolas O Chiron C. Prophylactic anti-epileptic treatment in Sturge-Weber disease. Seizure 2002;11(3):145\u2013150. doi:10.1053\/seiz.2001.0629.","journal-title":"Seizure"},{"issue":"6","key":"e_1_3_1_69_2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/cge.12223","article-title":"Incontinentia pigmenti diagnostic criteria update","volume":"85","author":"Mini\u0107 S","year":"2014","unstructured":"Mini\u0107 S Trpinac D Obradovi\u0107 M. Incontinentia pigmenti diagnostic criteria update. Clin Genet 2014;85(6):536\u2013542. doi:10.1111\/cge.12223.","journal-title":"Clin Genet"},{"issue":"2","key":"e_1_3_1_70_2","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1111\/ijd.13060","article-title":"Clinical study of 20 patients with incontinentia pigmenti","volume":"55","author":"Poziomczyk CS","year":"2016","unstructured":"Poziomczyk CS Bonamigo RR Santa Maria FD. Clinical study of 20 patients with incontinentia pigmenti. Int J Dermatol 2016;55(2):e87\u2013e93. doi:10.1111\/ijd.13060.","journal-title":"Int J Dermatol"},{"issue":"1","key":"e_1_3_1_71_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00784-012-0721-5","article-title":"Dental and oral anomalies in incontinentia pigmenti: a systematic review","volume":"17","author":"Mini\u0107 S","year":"2013","unstructured":"Mini\u0107 S Trpinac D Gabriel H. Dental and oral anomalies in incontinentia pigmenti: a systematic review. Clin Oral Investig 2013;17(1):1\u20138. doi:10.1007\/s00784-012-0721-5.","journal-title":"Clin Oral Investig"},{"issue":"1","key":"e_1_3_1_72_2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/jmg.30.1.53","article-title":"Incontinentia pigmenti (Bloch-Sulzberger syndrome)","volume":"30","author":"Landy SJ","year":"1993","unstructured":"Landy SJ Donnai D. Incontinentia pigmenti (Bloch-Sulzberger syndrome). J Med Genet 1993;30(1):53\u201359.","journal-title":"J Med Genet"},{"issue":"5","key":"e_1_3_1_73_2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ejmg.2012.04.007","article-title":"Neurologic findings in incontinentia pigmenti: a review","volume":"55","author":"Meuwissen MEC","year":"2012","unstructured":"Meuwissen MEC Mancini GMS. Neurologic findings in incontinentia pigmenti: a review. Eur J Med Genet 2012;55(5):323\u2013331. doi:10.1016\/j.ejmg.2012.04.007.","journal-title":"Eur J Med Genet"},{"issue":"6","key":"e_1_3_1_74_2","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3928\/23258160-20150610-09","article-title":"Incontinentia pigmenti: a comprehensive review and update","volume":"46","author":"Swinney CC","year":"2015","unstructured":"Swinney CC Han DP Karth PA. Incontinentia pigmenti: a comprehensive review and update. Ophthalmic Surg Lasers Imaging Retina 2015;46(6):650\u2013657. doi:10.3928\/23258160-20150610-09.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"}],"container-title":["Continuum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00132979-201802000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T14:07:09Z","timestamp":1752156429000},"score":1,"resource":{"primary":{"URL":"https:\/\/continuum.aan.com\/doi\/10.1212\/CON.0000000000000562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.1212\/CON.0000000000000562"],"URL":"https:\/\/doi.org\/10.1212\/con.0000000000000562","relation":{},"ISSN":["1080-2371","1538-6899"],"issn-type":[{"value":"1080-2371","type":"print"},{"value":"1538-6899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2]]}}}